Oakland, CA, United States of America

Simeon Bowers

USPTO Granted Patents = 25 

 

Average Co-Inventor Count = 6.4

ph-index = 4

Forward Citations = 37(Granted Patents)


Location History:

  • Cambridge, MA (US) (2018)
  • Oakland, CA (US) (2008 - 2024)

Company Filing History:


Years Active: 2008-2024

Loading Chart...
Loading Chart...
25 patents (USPTO):

Title: **Simeon Bowers: Innovator in PCSK9 Modulation**

Introduction

Simeon Bowers is a distinguished inventor based in Oakland, California, who has made significant contributions to the field of biopharmaceuticals. With a remarkable portfolio of 25 patents, Bowers focuses on novel compounds aimed at modulating the activity of proprotein convertase subtilisin/kexin type 9 (PCSK9), a key protein in cholesterol regulation.

Latest Patents

Bowers' latest patents include groundbreaking work on compounds designed to bind and modulate PCSK9 biological activity. These inventions include compositions and methods intended for therapeutic applications in treating PCSK9-related conditions and diseases. The first patent outlines novel compounds capable of modifying the biological interactions of PCSK9, while the second emphasizes the use of tetrahydroisoquinoline small molecules that influence circulating low-density lipoprotein (LDL) levels. By altering the conformation of the PCSK9 protein, these small organic compound ligands possess the potential to not only reduce high LDL-cholesterol levels associated with heart disease but also to raise LDL levels in situations requiring increased cholesterol.

Career Highlights

Simeon has had an impactful career, working with notable companies such as Srx Cardio, LLC and Elan Pharmaceuticals, Inc. His tenure at these establishments has solidified his expertise in the development of innovative biopharmaceutical solutions, particularly in the realm of cholesterol modulation.

Collaborations

Collaboration has been a cornerstone of Bowers' success. He has partnered with talented individuals such as Thomas E. Barta and Jonathan William Bourne, working collectively to advance therapeutic strategies for cholesterol management and related health conditions.

Conclusion

Simeon Bowers continues to trailblaze in the biopharmaceutical field, making substantial contributions to our understanding and treatment of cholesterol management. His innovative patents signify not only his expertise but also his commitment to addressing critical health challenges. As the landscape of biomedicine evolves, Bowers’ contributions are sure to play a pivotal role in the ongoing fight against diseases associated with cholesterol imbalances.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…